13F manager/RPRX/

Baillie Gifford trim Royalty Pharma plc

Baillie Gifford trim $431.2M of disclosed value in Royalty Pharma plc.

Signal
Investor Move
Action
Trim
Capital
$431.2M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence